Cargando…
Targeted Fe-doped silica nanoparticles as a novel ultrasound–magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer
BACKGROUND: Multimodal contrast agents with low toxicity and targeted modification have opened up new possibilities for specific imaging of breast cancer and shown broad application prospects in biomedicine and great potential for clinical transformation. In this work, a potential multifunctional im...
Autores principales: | Li, Xiaoyu, Xia, Shujun, Zhou, Wei, Ji, Ri, Zhan, Weiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455005/ https://www.ncbi.nlm.nih.gov/pubmed/31040664 http://dx.doi.org/10.2147/IJN.S189252 |
Ejemplares similares
-
Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents
por: Li, Xiaoyu, et al.
Publicado: (2021) -
Novel Magnetic Elastic Phase-Change Nanodroplets as Dual Mode Contrast Agent for Ultrasound and Magnetic Resonance Imaging
por: Riaz, Ramish, et al.
Publicado: (2022) -
New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009) -
Fabrication of Fe(III)-doped mesoporous silica nanoparticles as biocompatible and biodegradable theranostic system for Remdesivir delivery and MRI contrast agent
por: Arkaban, Hasan, et al.
Publicado: (2023) -
Organic nanoparticle-doped microdroplets as dual-modality contrast agents for ultrasound microvascular flow and photoacoustic imaging
por: Xu, Yu, et al.
Publicado: (2020)